Keytruda (pembrolizumab) - Merck (MSD)
osunprotafib (ABBV-CLS-484) - AbbVie, Calico Life Sciences
https://kcrs.kidneycan.org/wp-content/uploads/2026/07/KCRS26-Abstract-Book-July21.pdf
 
Hans Hammers MD PhD 1, 2; Emiliano Calvo MD PhD 3; Benedito A. Carneiro MD 4; Michael R. Harrison MD 5; Eric Jonasch MD 6; David Braun MD PhD 7; Do-Youn Oh MD PhD 8; Kartik Seghal MD 9; Ulka Vaishampayan MD 10; Noboru Yamamoto MD 11; Leisha A. Emens MD PhD 12; Jie Tang MS 12; Anh Nguyen PharmD 12; Nidhi Prem MD 12; Damian Trujillo PhD 12; Cathleen Hartman PhD 12; Marcia Paddock MD PhD 12; Jonathan Powell MD PhD 12; David McDermott MD 13
 
Jun 12, 2026
 
Prev Next